Liver Regeneration in the Transplant Setting

移植环境中的肝脏再生

• 批准号: 8013390
• 负责人: Kim Marie Olthoff
• 金额: $ 9.48万
• 依托单位: UNIVERSITY OF PENNSYLVANIA
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-03-15 至 2011-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8013390
• 关键词: Adult; Affect; Age; Allografting; Ancillary Study; Archives; Biology; Biopsy; Brain Death; Cell Cycle; Cell Cycle Progression; Characteristics; Child; Clinical; Clinical Management; Clinical Pathways; Clinical Research; Cohort Studies; Collaborations; Communities; DNA Microarray Chip; Data; Databases; Development; Diagnosis; Diagnostic; Equilibrium; Event; Excision; Failure; Functional disorder; Gene Expression; Gene Expression Profile; Gene Expression Profiling; Genes; Goals; Grant; Growth; Hepatic Mass; Hepatitis C; Hepatocyte; Homeostasis; Hour; Human; Inflammation; Inflammation Process; Inflammatory; Inflammatory Response; Injury; Institution; Investigation; Ischemia; Laboratories; Lead; Life; Link; Liver; Liver Dysfunction; Liver Regeneration; Liver diseases; Living Donor Liver Transplantation; Living Donors; Lobe; Metabolic; Metabolic Pathway; Modality; Modeling; Molecular; Molecular Profiling; Multicenter Studies; NIH Program Announcements; National Institute of Diabetes and Digestive and Kidney Diseases; Natural regeneration; Outcome; Pathway interactions; Patients; Process; Recovery; Recruitment Activity; Reperfusion Therapy; Research Personnel; Resolution; Rodent; Sampling; Shapes; Signal Transduction; Specimen; Staging; Syndrome; Testing; Therapeutic; Time; Tissues; Transplantation; Validation; Wound Healing; clinical research site; cohort; density; experience; graft failure; graft function; injured; liver biopsy; liver transplantation; prevent; programs; prospective; rapid growth; regenerative; research clinical testing; research study; response; success; theories; therapy design

DESCRIPTION (provided by applicant): The increase in the number of patients with end stage liver disease has led to rapid growth of the waitlist for transplantation and increased efforts to enlarge the donor pool with and adult-to-adult living donor (LD) liver transplantation. Fundamental differences between LD and deceased donor (DD) grafts are related to the differential magnitude of the proinflammatory response to ischemic injury, and the need for graft regeneration. During recovery and regeneration the liver must maintain metabolic and synthetic homeostasis, and if unable, the graft will express various degree of dysfunction. Although detailed models of liver injury and regeneration have been defined in rodents, the molecular specifics of how a human liver initiates mechanisms of recovery and regeneration following transplantation have yet to be clearly defined. Our first Aim is to determine and validate the molecular pathways that associated with the recovery within LD liver grafts in comparison to DD grafts. We hypothesize that early molecular proinflammatory and regeneration profiles may be diagnostic and predictive of subsequent graft function. Qualitative and quantitative failure to initiate and support the progression of molecular pathways of recovery will result in a spectrum of liver graft dysfunction. This Aim will utilize high density DNA microarrays to identify gene expression profiles linked through clinical outcome data to successful liver regeneration and graft recovery. The second Aim intends to determine the interrelation of donor and recipient clinical variables with the successful initiation and progression of recovery pathways in the allograft. Our hypothesis is that specific clinical conditions may contribute to the intensity of the proinflammatory response, impact on its resolution, affect cell cycle activation and subsequent regeneration, and present an overload on metabolic pathways in the allograft. The clinical expression of graft function under a given clinical condition may be diagnosed and predicted by gene expression profiles of proinflammatory and regenerative pathways in early and subsequent liver biopsies. Our hypothesis will be tested in the setting of DD and LD liver transplantation as an Ancillary study to the ongoing NIDDK multi-center Adult to Adult Living Donor Liver Transplant (A2ALL) consortium. This prospective cohort study will be used to recruit patients and follow clinical outcomes. The results of this study may be used for the diagnosis and management of clinical conditions in the immediate post liver transplant period. Understanding the mechanistic biology of graft recovery and pathways of liver regeneration will provide important data for designing treatment modalities that will prevent injury and enhance recovery and regeneration.

描述（由申请人提供）：终末期肝病患者数量的增加导致移植等待名单的快速增长，并加大了扩大供体库和成人对成人活体供体（LD）肝移植的努力。LD和死亡供体（DD）移植物之间的根本差异与缺血损伤的促炎反应的不同程度以及移植物再生的需要有关。在恢复和再生过程中，肝脏必须维持代谢和合成的稳态，如果不能，移植物将表现出不同程度的功能障碍。尽管啮齿类动物肝脏损伤和再生的详细模型已经确定，但人类肝脏如何启动移植后恢复和再生机制的分子细节尚未明确定义。我们的第一个目的是确定和验证LD肝移植与DD肝移植恢复相关的分子途径。我们假设早期分子促炎和再生特征可以诊断和预测随后的移植物功能。定性和定量失败启动和支持分子恢复途径的进展将导致一系列肝移植功能障碍。该目标将利用高密度DNA微阵列来识别通过临床结果数据与成功的肝脏再生和移植恢复相关的基因表达谱。第二个目的是确定供体和受体临床变量与成功启动和进展的恢复途径在同种异体移植物的相互关系。我们的假设是，特定的临床条件可能有助于促炎反应的强度，影响其消退，影响细胞周期激活和随后的再生，并在同种异体移植物中呈现代谢途径过载。在特定的临床条件下，移植物功能的临床表达可以通过早期和随后的肝活检中促炎和再生途径的基因表达谱来诊断和预测。我们的假设将在DD和LD肝移植的背景下进行检验，作为正在进行的NIDDK多中心成人到成人活体肝移植（A2ALL）联盟的辅助研究。这项前瞻性队列研究将用于招募患者并跟踪临床结果。本研究结果可用于肝移植术后即刻临床状况的诊断和管理。了解移植物恢复的机制生物学和肝脏再生途径将为设计治疗模式提供重要数据，以防止损伤和增强恢复和再生。